Boundless Bio, Inc.BOLDNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -23.63% | +0.27% | +1.51% | +0.59% | +31.65% |
| Weighted Average Shares Diluted Growth | -23.63% | +0.27% | +1.51% | +0.59% | +31.65% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +58.91% | +63.35% | -4.65% | -3.64% | -23.91% |
| Book Value per Share Growth | +0.00% | +0.00% | -32.57% | -33.66% | -50.26% |
| Debt Growth | +2070.02% | +3089.36% | +5815.17% | +41023.14% | +2.95% |
| R&D Expense Growth | +27.85% | -7.55% | -17.75% | -26.45% | -21.56% |
| SG&A Expenses Growth | +46.78% | +38.60% | +4.02% | -3.26% | -15.67% |